Douglas Pharmaceuticals was founded in 1967 by Managing Director Graeme Douglas MNZM FPS.  The company remains one of the fastest growing pharmaceutical companies in Australasia.

Outstanding customer services is the key to the success of Douglas Pharmaceuticals with the company being consistently ranked as the top performing company in New Zealand IMS surveys on pharmacist satisfaction.

Douglas Pharmaceuticals is currently enjoying significant growth in expanding world-wide export revenues.

Considerable investment in product development laboratories and a specially designed containment suite for steroid manufacture signals the company's intention to present its international clients with high quality products, supported through the timely provision of fully compliant registration dossiers in CTD format.

Douglas Pharmaceuticals has two large, modern manufacturing plants in New Zealand and Fiji. They have the capacity to produce pharmaceuticals, dietary supplements, animal remedies, nutriceuticals and cosmetics in a variety of forms - solid oral dose and liquid - for both Douglas Pharmaceuticals and joint venture partners. At our manufacturing plants we also boast laboratories that offer state-of-the-art analytical testing facilities along with new product development investigations.

Douglas Pharmaceuticals invites inquiries for its contract manufacturing, product development and analytical testing services. All manufacturing contract and laboratory work will be undertaken in the strictest of confidence.

Our manufacturing plants and laboratories are licensed by the TGA (Therapeutic Goods Administration of Australia), the New Zealand Ministry of Health and MAF (New Zealand Ministry of Agriculture and Fisheries) for the manufacture of both animal remedies and dairy products. The New Zealand Ministry of Health also has in place a Mutual Recognition Agreement that allows Douglas Pharmaceuticals to export the pharmaceutical products it manufactures into the European Union and Asia. 

Core Sales Territory: Global Regulated Markets

Core Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, Distribution

Number of molecules sold: > 20

Company's rating: